Status:

COMPLETED

Hs-Troponin T Kinetics in Patients Treated With MCO Membranes Compared to High-flux, Low-flux Membranes and HDF

Lead Sponsor:

Medical University of Graz

Conditions:

Troponin T

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In this study, 24 prevalent hemodialysis patients will undergo four regular hemodialysis sessions during which four different treatments will be performed. * Treatment 1: MCO membrane (=medium cut of...

Detailed Description

Patients who are on hemodialysis will be included in this study. After obtaining informed consent, patients will be treated with four different hemodialysis sessions: * Treatment 1: MCO membrane (=me...

Eligibility Criteria

Inclusion

  • minimum 18 years of age
  • End stage kidney disease patient undergoing hemodialysis
  • Written consent of the participant after being informed

Exclusion

  • No informed consent was obtained
  • Pregnancy

Key Trial Info

Start Date :

August 12 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 24 2022

Estimated Enrollment :

22 Patients enrolled

Trial Details

Trial ID

NCT05439681

Start Date

August 12 2022

End Date

December 24 2022

Last Update

March 2 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of Graz

Graz, Austria